Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia
Clinical trial NCT00082940 · COMPLETED
Trial details
- NCT number
- NCT00082940
- Sponsor
- Wake Forest University Health Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-08-01
- Primary completion
- 2005-01-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.